Suzuki Kenji, Asamura Hisao, Watanabe Shun-ichi, Tsuchiya Ryosuke
Thoracic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Ann Thorac Surg. 2004 Oct;78(4):1184-9; discussion 1184-9. doi: 10.1016/j.athoracsur.2004.04.066.
Combined resection of the superior vena cava (SVC) for lung carcinoma remains challenging in terms of technical aspect and prognosis. We attempted to clarify the surgical outcome of combined resection and reconstruction of the SVC for lung carcinoma.
Between March 1980 and May 2001, among 3,499 lung resections, 40 (1.1%) patients underwent combined resection of the SVC. Thirty-four were men and 6 were women. Ages ranged from 37 to 77 years, with median of 64 years. Lobectomy and pneumonectomy was performed in 19 and 21 patients, respectively. The SVC system was totally resected and reconstructed with grafts in 11 patients, and partially resected in 29 patients. For the latter patients, autologous pericardial patches were used in 8 patients, and a running direct suture was performed in 21 patients. The survival curves were constructed by the method of Kaplan-Meier, and the curves were compared using the log-rank test.
Thirty-day mortality was 10%. The 5-year survival rate was 24%, with the median follow-up period for living patients 67 months (actual 5-year survivors were 7). The prognoses were compared between patients with SVC invasion by metastatic nodes (n = 15) and those with SVC invasion by a direct tumor extension (n = 25), and the survival difference was statistically significant (5-year survival rate, 6.6% versus 36%; p = 0.05).
The pattern of SVC invasion was considered to be a significant prognostic factor, and this factor should be taken into consideration for evaluating the outcome of clinical trials for T4 lung cancer.
肺癌合并上腔静脉(SVC)切除在技术层面和预后方面仍然具有挑战性。我们试图阐明肺癌合并SVC切除及重建的手术结果。
在1980年3月至2001年5月期间,在3499例肺切除病例中,40例(1.1%)患者接受了SVC联合切除。男性34例,女性6例。年龄范围为37至77岁,中位年龄为64岁。19例和21例患者分别进行了肺叶切除和全肺切除。11例患者的SVC系统被完全切除并用移植物重建,29例患者的SVC系统被部分切除。对于后一组患者,8例使用了自体心包补片,21例进行了连续直接缝合。采用Kaplan-Meier方法构建生存曲线,并使用对数秩检验比较曲线。
30天死亡率为10%。5年生存率为24%,存活患者的中位随访期为67个月(实际5年幸存者为7例)。比较了转移性淋巴结侵犯SVC的患者(n = 15)和肿瘤直接侵犯SVC的患者(n = 25)的预后,生存差异具有统计学意义(5年生存率,6.6%对36%;p = 0.05)。
SVC侵犯模式被认为是一个重要的预后因素,在评估T4期肺癌的临床试验结果时应考虑这一因素。